相关实验视频

Updated: Sep 13, 2025

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

子宫内膜癌中的免疫微环境:机制和治疗向

Yilin Wang^1,2, Nana Liu^1,2, Xiangcui Guo^1,2,3

¹Xinxiang Medical University, Xinxiang, China.

Frontiers in immunology

|August 1, 2025

概括

子宫内膜癌的进展受到瘤免疫微环境 (TME) 的影响. 针对TME组件提供了新的策略,以改善治疗耐药性和子宫内膜癌患者的治疗结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
妇科瘤学妇科瘤学

背景情况:

子宫内膜癌 (EC) 是一种正在上升的妇科恶性瘤,晚期预后不佳.
瘤免疫微环境 (TME) 显著影响EC的发作,进展,转移和治疗耐药性.
关键的TME组件包括瘤相关的巨细胞 (TAMs),骨髓系衍生抑制细胞 (MDSCs),癌症相关的纤维细胞 (CAFs),免疫细胞和细胞外基质 (ECM).

研究的目的:

审查目前对子宫内膜癌瘤免疫微环境 (EC-TME) 的理解.
阐明EC-TME成分在子宫内膜癌生物学中的作用和相互作用.
探索针对TME的新型治疗策略,以改善EC患者的治疗结果.

主要方法:

文献综述综合了关于EC-TME的当前研究.
分析TAMs,MDSCs,CAFs,免疫细胞和ECM在EC中的作用.
探索治疗方法,包括免疫检查点抑制剂,组合疗法和基于EV的纳米输送系统.

主要成果:

TME通过细胞因子,细胞外囊泡 (EV) 和免疫检查点通路 (例如PD-1/PD-L1) 创建了一个免疫抑制环境.
这些TME元素促进瘤免疫逃避和子宫内膜癌的治疗耐药性.
对于EC的发展和进步来说,TME组件之间的明确相互作用至关重要.

结论:

了解EC-TME对于开发有效的子宫内膜癌疗法至关重要.
针对TME组件和途径,为克服治疗耐药性提供了有希望的途径.
新的策略,如免疫检查点抑制剂和基于EV的疗法,有可能改善EC患者的治疗结果.

关键词:

宫内膜癌 (Endometrial Carcinoma) 是一个体内膜癌.免疫逃避免疫逃避免疫疗法免疫疗法有针对性的治疗.治疗抵抗性的治疗.瘤免疫的微环境

更多相关视频

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

A Proximal Culture Method to Study Paracrine Signaling Between Cells

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...